Vivek Narayan

PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial

Vivek Narayan, Julie S. Barber-Rotenberg, In-Young Jung et al. · Nature Medicine · 2022 · 500 citations · Full text

Medicine, Oncology, Pharmacology +14

Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial

Padmanee Sharma, Russell K. Pachynski, Vivek Narayan et al. · Cancer Cell · 2020 · 393 citations · Full text

Medicine, Oncology, Pharmacology +15

A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial

Sumanta K. Pal, Catherine M. Tangen, Ian M. Thompson et al. · The Lancet · 2021 · 279 citations · Full text

Medicine, Oncology, Pharmacology +11

Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study

Nieves Martínez Chanzá, Wanling Xie, Mehmet Asım Bilen et al. · The Lancet Oncology · 2019 · 175 citations

Medicine, Oncology, Pharmacology +11

Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction

Biniyam G. Demissei, Rebecca A. Hubbard, Liyong Zhang et al. · Journal of the American Heart Association · 2020 · 163 citations · Full text

Medicine, Cardiology, Oncology +17